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-Wave Alternans and
he Susceptibility to Ventricular Arrhythmias
anjiv M. Narayan, MB, MD, FACC
an Diego and La Jolla, California
T-wave alternans (TWA) reflects beat-to-beat fluctuations in the electrocardiographic
T-wave, and is associated with dispersion of repolarization and the mechanisms for sudden
cardiac arrest (SCA). This review examines the bench-to-bedside literature that, over
decades, has linked alternans of repolarization in cellular, whole-heart, and human studies
with spatial dispersion of repolarization, alternans of cellular action potential, and fluctuations
in ionic currents that may lead to ventricular arrhythmias. Collectively, these studies provide
a foundation for the clinical use of TWA to reflect susceptibility to ventricular arrhythmias
in several disease states. This review then provides a contemporary evidence-based framework
for the use of TWA to enhance risk stratification for SCA, identifying populations for whom
TWA is best established, those for whom further studies are required, and areas for additional
investigation. (J Am Coll Cardiol 2006;47:269–81) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.08.066Cardiology Foundation
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tudden cardiac arrest (SCA) claims over 400,000 lives
er year in the U.S. alone, predominantly from ventric-
lar tachycardia (VT) or ventricular fibrillation (VF) (1).
lthough prophylaxis with the implantable cardioverter
efibrillator (ICD) is extremely effective (2–4), identify-
ng individuals who should receive such therapy remains
hallenging. Certainly, reduced systolic function (4) and
eart failure (5,6) are sensitive indices of SCA risk, yet
hey identify populations in whom arrhythmic event rates
ay be low (7). From an individual as well as a public
ealth perspective, there is therefore an urgent need for
ore accurate indices of lethal ventricular arrhythmias.
T-wave alternans (TWA) is a promising electrocardio-
raphic (ECG) index that measures beat-to-beat alternation
n T-wave shape, amplitude, or timing. Decades of research
ow link TWA with inducible (8–10) and spontaneous
11–13) clinical ventricular arrhythmias, and with basic
echanisms leading to their initiation (14). This bench-to-
edside foundation makes TWA a very plausible index of
usceptibility to SCA, and motivates the need to define
ptimal conditions for its detection and clinical populations
n whom its potential can be realized.
HENOMENOLOGY AND HISTORY OF TWA
T-wave alternans” refers to alternation of the ECG
T-segment (9,15), T- and U-wave (16), and is also
ermed repolarization alternans (10,17). T-wave alter-
From the University of California, San Diego, and the Veterans Affairs Medical
enter, La Jolla, California. This work was supported by grants from the National
eart, Lung, and Blood Institute (HL 70529) and the American Heart Association
0265120Y). Dr. Narayan has received speaking honoraria from Guidant Corporation
nd Cambridge Heart, Inc.s
Manuscript received May 9, 2005; revised manuscript received July 20, 2005,
ccepted August 1, 2005.ans refers to primary T-wave fluctuations as opposed to
-wave fluctuations secondary to electrical alternans to-
alis (alternans of all ECG components, such as in
ericardial effusion) or QRS alternans. Visible TWA was
rst reported in the early 1900s during tachycardia and
schemia in remarkable observations by Hering (18) and
ir Thomas Lewis (19). Subsequently, visible TWA of
ncreasing subtlety (Figs. 1A to 1C) has been reported in
atients with ischemia (11), long QT syndrome (LQTS)
20), electrolyte disturbances, and conversion from tachy-
ardia (21), and consistently linked with ventricular
rrhythmias (22,23).
The contemporary use of TWA relies upon microvolt-
evel fluctuations (Fig. 1D) that are invisible to the unaided
ye yet revealed by computerized signal processing methods
8,15,24).
WA: A SYSTEMS-LEVEL APPROACH
onceptually, electrical stability of the ventricle lies along a
pectrum from regular rhythms to VF. It is now felt that
F, rather than being random, exhibits features of chaotic
ystems because it is sensitive to initiating conditions and
emonstrates characteristic scaling properties (25). In this
ontext, alternans of repolarization (the T-wave) may be
onsidered to be a bifurcation point (26,27) preceding VF.
oreover, when canine hearts are paced under pro-
rrhythmic conditions (norepinephrine administration),
hey show period doubling (TWA) (26) and, with ischemia,
urther multupling to higher-order T-wave oscillations im-
inently preceding VF (28) (Fig. 2). Under such condi-
ions, therefore, repolarization alternans may represent one
tep in an “orderly” transition to VF.
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TWA and Arrhythmia Susceptibility January 17, 2006:269–81ATHOPHYSIOLOGY OF TWA
ork in many preparations has shown that TWA reflects
patial (29) or temporal (14) dispersion of repolarization
Fig. 3), both of which may precede VF (25,30), although
he precise pathophysiology underlying microvolt TWA in
igure 1. T-wave alternans (TWA) of increasing subtlety detected throu
ngina pectoris preceding ventricular tachycardia (VT); (B) Visible alterna
C)Subtle but visible TWA after tachycardia termination, without arterial pre
Abbreviations and Acronyms
APD  action potential duration
DI  diastolic interval
ECG  electrocardiography
EPS  electrophysiologic study
HCM  hypertrophic cardiomyopathy
ICD  implantable cardioverter-defibrillator
LQTS  long QT syndrome
LV  left ventricular
LVEF  left ventricular ejection fraction
MADIT  Multicenter Automatic Defibrillator
Trial
MASTERS  Microvolt T-wave Alternans
Testing for Risk Stratification of
post-MI patients
MI  myocardial infarction
MMA  Modified Moving Average
MUSTT  Multicenter Unsustained
Tachycardia Trial
NICM  non-ischemic cardiomyopathy
RR  relative risk
SAECG  signal-averaged ECG
SCA  sudden cardiac arrest
TWA  T-wave alternans
VF  ventricular fibrillation
VT  ventricular tachycardiay digital signal processing (8,23). *The more positive T-wave of each alternati
was reprinted with permission from reference 22, Copyright ©2006 Massachusettumans has not been delineated. In particular, it is unclear
ow microvolt TWA relates to visible TWA preceding VT
r VF (Fig. 1B), although they seem analogous in some
tudies (14,31).
PATIAL DISPERSION OF REPOLARIZATION AND TWA
patial variations in repolarization (action potential dura-
ion [APD], or shape) (29) or conduction velocity (32,33)
ay prevent depolarization in myocytes that are still repo-
arizing from their last cycle (Fig. 3 left, region 1). Not only
ay this cause 2:1 behavior (alternans) and TWA (14), but
nidirectional block may occur at sites of delayed repolar-
zation, thus facilitating re-entry. Importantly, pro-
rrhythmic events such as ischemia (34) and extrasystoles
14) have been shown to cause repolarization alternans by
xaggerating spatial gradients in repolarization. Under crit-
cal conditions, ischemia (34) or extrasystoles (34,35) may
everse the phase of cellular alternans in one tissue region,
ausing discordant alternans (that is, out-of-phase between
egions) and leading to unidirectional block and VF (14).
EMPORAL DISPERSION OF
EPOLARIZATION, APD ALTERNANS, AND TWA
-wave alternans may also result from the complementary
echanism of temporal dispersion of repolarization, or
lternans of action potential shape or APD (Fig. 3, right)
29). Action potential duration alternans may follow accel-
rated pacing in human atria (36) ventricles (37), and
e years. (A) Gross alternans of elevated ST/T-segments in a patient with
T-wave polarity in a woman without angina, heralding polymorphic VT;
alternans (bottom); (D)Visually inapparent microvolt-level TWA, uncoveredgh th
ns of
ssureng pair. Panel A was reprinted with permission from reference 11. Panel
s Medical Society. Panel C was reprinted with permission from reference 21.
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January 17, 2006:269–81 TWA and Arrhythmia Susceptibilityangendorff-perfused ventricles (14), and, under certain
onditions, may lead to conduction block and fibrillation.
Action potential duration alternans is facilitated by the
echanism of steep restitution. Action potential duration
estitution expresses the relationship between the APD of
ne beat and the diastolic interval (DI) interval separating
ts upstroke from the preceding action potential (37) (Fig. 3,
igure 2. “Orderly transition” from stable rhythm, via T-wave alternans (
earts after the onset of ischemia (times in min:s) show period doubling to
gainst its successor). Further multupling causes higher-order oscillations,
igure 3. Mechanisms underlying T-wave alternans (TWA). (Left) spatia
otential duration (APD) and depolarizes every other cycle (beats 1 and
lternates between cycles, either from alternans of cytosolic calcium (not sh
he relationship of APD to diastolic interval (DI), the interval separating the cur
I shortening abruptly shortens APD, which abruptly lengthens the next DI aottom right). If APD restitution is steep (maximum slope
1; Fig. 3, bottom right), small changes in DI from a
lightly early beat, for example, cause large APD fluctua-
ions that facilitate alternans (38). Under certain conditions
39), this may lead to wavefront fractionation and VF (25).
ecent data suggest that steep restitution in conduction
elocity (32,33), reflecting analogous rate-related behavior
), to ventricular fibrillation (VF). Electrocardiograms (ECGs) of canine
A, i.e., two clusters in the Poincarré plot (T-wave amplitude of each beat
lex forms, and then VF. Reprinted with permission from reference 28.
rsion of repolarization. Compared to region 2, region 1 has longer action
Right) Temporal dispersion of repolarization. Action potential duration
or steep APD restitution. Action potential duration restitution (inset) isTWAl dispe
3). (
own)rent action potential from the prior one. If restitution is steep (slope 1),
nd APD, leading to APD alternans.
i
c
a
m
v
s
f
a
R
c
e
t
a
f
c
(
a
m
t
(
(
C
O
S
d
w
a
b
H
T
a
i
h
p
t
h
i
p
T
a
r
E
m
b
t
o
T
t
a
(
T
e
M
T
F
a
r
F
s
p
p
(
a
a
n
s
I
i
s
w
h
n
f
v
r
b
a
N
h
t
r
p
m
T
T
m
i
a
p
T
o
“
M
S
c
t
o
p
t
d
b
o
P
272 Narayan JACC Vol. 47, No. 2, 2006
TWA and Arrhythmia Susceptibility January 17, 2006:269–81n conduction, and effects from several prior DI (32,39) also
ontribute to APD alternans and arrhythmias.
Alternans of cytosolic calcium (40,41) may underlie APD
lternans at an ionic level (42). Normally, calcium enters the
yocyte via voltage-gated L-type Ca2 channels and acti-
ates ryanodine receptors to trigger calcium release, from
arcoplasmic reticulum, and contraction. A recirculating
raction of this calcium is sequestered by Ca2ATPase,
nd the remainder is extruded by the NaCa2exchanger.
apid heart rates may overload this homeostatic capacity to
ause alternans of calcium cycling (40,43) and APD, via
ffects on membrane currents (42,44). Calcium accumula-
ion may explain hysteresis in repolarization alternans (45)
nd TWA (10), such that alternans is larger in magnitude
ollowing deceleration from a rapid heart rate. Impaired
alcium cycling may facilitate APD alternans in heart failure
46). Calcium cycling also links electrical with mechanical
lternans (35,41) and explains why, in some preparations,
echanical alternans precedes electrical alternans (43).
Finally, APD alternans during ischemia may also follow
ransmural differences in potassium channel (KATP) activity
47), reduced ATP availability (48), or cellular uncoupling
49).
LINICAL MEASUREMENT
F TWA FROM THE ECG
everal methods exist to measure TWA. Spectral analysis
uring controlled heart rate acceleration has been the most
idely applied to date (50), yet alternative methods of
nalysis (51) during ambulatory activity (23) may eventually
roaden the scope of TWA testing.
eart rate and other conditions for TWA measurement.
-wave alternans occurs at elevated heart rates, although at
lower threshold in patients at risk for SCA than in normal
ndividuals (10). Typically, therefore, TWA is measured at
eart rates above rest but below rates likely to cause false
ositives. Exercise (12,52) and pacing (9,53) (indicated by
he † symbol in Table 1) have both been used to accelerate
eart rate for TWA analysis, and both have merits. Exercise
s convenient and was superior in some studies (52), yet
acing has recently been shown to reduce indeterminate
WA tests (54), and prevents rate fluctuations that may
rtifactually elevate TWA (10,45). Important recent work
eveals TWA at times of higher heart rate in ambulatory
CGs (23) that, hypothetically, may reflect the diurnal
ilieu predisposing to SCA.
It is generally felt that beta-blocking medications should
e continued while assessing TWA (55), although interac-
ions with the autonomic nervous system are unclear. On
ne hand, beta-blockade (56) and sotalol (55) attenuate
WA, reflecting antiarrhythmic effects and improved sys-
olic function (57). On the other, beta-stimulation does not
lways augment TWA (58). Procainamide (59), amiodarone
60), and calcium-channel antagonists (61) also attenuate aWA, with unclear impact on its diagnostic accuracy. The
ffects of digoxin on TWA are unclear.
easuring TWA spectrally. Spectral analysis (8,15) treats
WA as a signal superimposed upon every other T-wave.
or the consecutive ECG beats aligned in Figure 4A,
lternans at any time point within the T-wave (arrows)
esults in oscillations (“up-down-up”) between beats. Fast
ourier transformation represents these oscillations as the
pectral peak at 0.5 cycles/beat. Spectra from all T-wave
oints are then summated. In the summated spectrum, the
eak at 0.5 cycles/beat defines the magnitude of alternans
T), distinct from respiratory modulation (“Resp.”) and
djacent spectral noise. T-wave alternans is then quantified
s the (a) voltage of alternation (Valt) equal to (T-spectral
oise)/T-wave duration; and (b) k-score, equal to T/noise
tandard deviation.
nterpretation of spectral TWA test results. Criteria for
nterpreting TWA from the most widely used commercial
ystem (Cambridge Heart, Bedford, Massachusetts) are
ell-described (62), yet are rather detailed. It is therefore
elpful if TWA is interpreted by an experienced practitio-
er. Positive TWA (Fig. 4B) is defined as TWA sustained
or 1 min with Valt 1.9 V and k-score  3.0, in any
ector (X, Y, Z), or two precordial ECG leads, if onset heart
ate 110 beats/min. Positive TWA must also have 10%
ad beats and 2 V spectral noise without artifactual
lternans from breathing or relative risk (RR) alternans.
egative TWA is the absence of positive TWA as long as a
eart rate 105 beats/min was achieved (“maximum nega-
ive heart rate”), whereas indeterminate TWA classifies other
esults. Of many additional criteria (62), recent studies in
atients with left ventricular (LV) dysfunction following a
yocardial infarction (MI) (labeled with the ‡ symbol in
able 1) used the simple approach of identifying negative
WA, then grouping all other tests (positive and indeter-
inate) as “abnormal” TWA. This is helpful because
ndeterminate results occur in 9% to 47% of tests, but seem
ppropriate only if indeterminacy reflects ectopy, which
redicts adverse outcome, rather than ECG noise (62).
ime-domain analyses of TWA. Time-domain analysis
f TWA involves subtracting T-waves of “even” versus
odd” beats (Fig. 1D), as in the commercially available
odified Moving Average (MMA) method (23) (GE
ystems, Milwaukee, Wisconsin). Time-domain analysis
an theoretically measure shorter-duration TWA than spec-
ral analysis and, in preliminary studies, TWA measured
ver 15 s stratified SCA risk from ambulatory ECGs in
atients after MI (23).
However, the promise of MMA for ambulatory TWA
esting is currently limited by the absence of established
iagnostic criteria. Furthermore, its sensitivity is unclear
ecause TWA detected by MMA (25 to 100 V) was an
rder of magnitude greater than detected spectrally (23).
rospective studies are required to compare the predictive
ccuracy of TWA using MMA and spectral methods.
Table 1. Studies Linking TWA With Ventricular Arrhythmias in Patients With Post-MI LV Dysfunction
Authors (Reference) No. of Patients
LVEF,
%
CAD,
%
CHF
Class End Point
No. End
Points Follow-Up
% Ind
TWA Sens Spec PPV NPV RR
Predicting inducible VT/VF
at EPS
Smith et al. (8)† 19 — 84 — VT, VF 13 — — 92 50 71 83 —
Estes et al. (91) 27 51  14 41 — VT, VF 10 — 47 89 75 67 92 8.7
Narayan and Smith (10)† 60 41 83 — VT, VF 36 — — 88 65 79 78 —
Predicting spontaneous SCA
Rosenbaum et al. (9)† 66 follow-up (83 total) — 64 — VT, VF 13 20 months — — — — — 4.5
Hohnloser et al. (74)† 95 36  14 75 — ICD Rx 41 442  210 days 18 78 61 67 73 2.5
71 (CAD) 100 85 68 73 81 3.9
Gold et al. (12) 215 (high-risk subgroup) 39  18 55 — SCA, ICD Rx,
mortality
15 195  126 days 24 — — — — 8.0
Verrier et al. (23) 44 42 100 — SCA, VT, VF 14 21  8 months N/A — — — — 7.9
Rashba et al. (68) 144 28  7 100 2.1 VT, VF, ICD Rx 50 509  387 days 25 82 43 40 84 2.2
Narayan et al. (53)† 59 39 100 — VT, VF mortality 25 36  12 months — 96 32 55 90 —
Predicting mortality
(post-MI, LVEF
30%)
Hohnloser et al. (65)‡ 129 26  5 100 — SCA, VT, VF 20 17  8 months 13 — — — — 5.5
Bloomfield et al. (13)‡ 177 23  6 100 1.8 All-cause mortality 23 20  6 months 41 — — 14* 96* 3.55
*From meta-analysis (50). †TWA elicited by pacing in some/all patients. ‡Indeterminate TWA was grouped with positive TWA.
CAD  coronary artery disease; CHF  congestive heart failure; EF  ejection fraction; EPS  electrophysiologic study; ICD Rx  implantable cardioverter-defibrillator therapy for ventricular arrhythmias; Ind  indeterminate
TWA test; LV  left ventricle; MI  myocardial infarction; NPV  negative predictive value; PPV  positive predictive value; RR  relative risk; SCA  sudden cardiac arrest; TWA  T-wave alternans; VF  ventricular fibrillation;
VT  ventricular tachycardia; —  data not available.
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TWA and Arrhythmia Susceptibility January 17, 2006:269–81NCORPORATING TWA INTO CLINICAL
ISK STRATIFICATION ALGORITHMS
-wave alternans is best established for stratifying susceptibil-
ty to SCA in high-risk patients (50) with reduced left
entricular ejection fraction (LVEF) and coronary disease
2–4) or heart failure (5). The excellent negative predictive
alue of TWA in these populations identifies individuals with
very low event rate (Tables 1 and 2), and TWA has therefore
een suggested as a component of the proposed national
utcomes database for primary ICD therapy (63). Although
WA also stratifies risk in SCA survivors (50), their risk is
lready well-established, and TWA is less validated in other
opulations. Scenarios where TWA enhances risk stratification
or primary SCA are illustrated in Figure 5, summarized in
ables 1 and 2, and discussed in detail in the following text.
WA in patients with coronary disease and LVEF
30%. The second Multicenter Automatic Defibrillator
rial (MADIT-2) showed that patients with coronary
isease and LVEF 30% benefit from empiric ICD im-
lantation (4); this is likely most beneficial for patients
igure 4. (A) Spectral computation of T-wave alternans (TWA). In the
vertical arrows) results in down-up-down oscillations. Fast Fourier transf
scillations causes the 0.5 cycles/beat peak (T). In the final spectrum (sum
-score (see panel B).hose MI occurred at least 40 days previously (64). Poten- fially, negative TWA may identify individuals in this
opulation with a low arrhythmic event rate (7).
In 177 patients of the MADIT-2 type studied by Bloom-
eld et al. (13), negative TWA predicted improved survival
ver 20  6 months’ follow-up compared with abnormal
WA, providing a negative predictive value of 96% (50)
Table 1). Therefore, although 18 ICD implants were
equired to save one life in MADIT-2 (4), by also requiring
bnormal TWA this number needed to treat falls to seven
13). In a retrospective study by Hohnloser et al. (65) of 129
imilar patients, those with negative TWA had no arrhyth-
ic mortality after 24 months, versus 15.6 % in those with
bnormal TWA (Table 1).
Therefore, in patients of the MADIT-2 type, the addi-
ion of negative TWA identifies a very low-risk population.
ombining LVEF and TWA as primary and secondary
ndices is likely more powerful than using either alone (50),
nd additional combinations should be studied. The just-
ompleted Microvolt T-wave Alternans Testing for Risk
tratification of post-MI patients (MASTERS) study may
nal aligned ECG beats, alternans at each time point within the T-wave
ion (FFT) yields a spectrum, in which the alternating component of these
ed for all time points), T is related to spectral noise to compute Valt andorigi
ormat
maturther clarify these issues by prospectively testing the
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January 17, 2006:269–81 TWA and Arrhythmia Susceptibilityredictive value of TWA for arrhythmic events and mor-
ality in 600 MADIT-2 type patients and 1,200 registry
atients with LVEF 31% to 40%.
WA in patients with coronary disease and LVEF 31%
o 40%. Risk stratification for SCA is less defined in this
opulation, since individuals with lower LVEF (30%)
ere also included in the Multicenter Unsustained Tachy-
ardia Trial (MUSTT) study (required LVEF 40%; mean
VEF 30% [3]) and the first MADIT study (required
VEF 35%; mean LVEF 26% [2]). However, in
USTT patients with LVEF 31% to 40%, lower risk was
dentified by the absence of inducible arrhythmias at elec-
igure 4 Continued. (B) Positive TWA (from commercial system) shows (
o V6) with (ii) k-score 3 (gray shading) for 1 min (here 5 min), at (
nd 2 V noise, without (v)artifactual alternans (see text). Black horizorophysiologic study (EPS). However, the fact that EPS- hegative individuals still suffer substantial arrhythmic risk
66) motivates the need for alternative indices.
In the TWA Labeling Study, Gold et al. (12) showed
hat TWA predicted arrhythmic and overall mortality better
han EPS. Their population was mixed, yet in 215 patients
t high SCA risk (LVEF 39  18%, 55% with coronary
isease; Table 1) negative TWA predicted one-year ar-
hythmic mortality 10%, while positive TWA had RR for
T/VF of 8.0, versus 3.0 for EPS. In another study of 248
atients, TWA predicted VT, VF, and all-cause mortality
n 123 patients with varying structural heart diseases (67).
herefore, one caveat of these studies is their enrollment of
1.9 V in two precordial or one vector lead (here Valt4 to 6 V in V3
nset rate 110 beats/min (here 100 beats/min), with (iv) 10% bad beats
ars indicate periods when conditions for positive TWA are met.i) Valt
iii) o
ntal beterogeneous patient populations.
Table 2. Studies Linking TWA with Ventricular Arrhythmias in Patients With Heart Failure, or After MI
Authors (Reference)
No. of
Patients LVEF, %
CAD,
%
CHF
Class End Point
End
Points Follow-Up
% Ind
TWA Sens Spec PPV NPV RR
Predicting SCA (patients with
CHF, NICM)
Adachi et al. (92) 58 FS 19% — 1.6  0.8 VT 16 No F/U Prior VT 17 88 72 — — Acc  77 %
Hennersdorf et al. (93) 60 57.5 0 1.63 VT, VF 16 6 months 9 65 98 30* 100* 4.45*
Klingenheben et al. (76) 107 28  7 65 2 VT, VF 13 14.6 months 21 — — 21* 100* Infinity
Kitamura et al. (70) 104 41  13 0 1.7  0.7 VT, VF 12 21  14 months 20 92 51 24 97 8.8
Hohnloser et al. (69) 137 29  11 0 — SCA, VT, VF,
ICD Rx
18 14  6 mo 27 87 38 22 94 3.44
Grimm, MACAS et al.
(71)
263 30  10 0 2.1 VT, VF, mortality
Transpl
38 52  21 months 21 — — 13* 90* NP (1.3)
Predicting SCA (after MI)
Ikeda et al. (78) 834 51% (in 149,
LVEF 40)
100 — SCA or VF 25 25  13 months 12 92 99 7* 100* 11.4
Ikeda et al. (73) 119 28 with
LVEF 40
100 — VT, VF 15 13  6 months — 93 59 28 98 16.8
Tapanainen et al. (77) 379 45  9.6 100 1.5 Mortality 26 14  8 months 14 — — 0* 99* NP; for Ind,
RR  15
Schwab et al. (79) 140 56  14 100 — Mortality VT/VF 3 451  210 days 26 — — 4* 99* NP
*From meta-analysis (50).
Acc  diagnostic accuracy; FS  fractional shortening; MACAS  Marburg cardiomyopathy study; NICM  non-ischemic cardiomyopathy; NP  non-predictive; Transpl  heart transplant; —  data not available; other
abbreviations as in Table 1.
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January 17, 2006:269–81 TWA and Arrhythmia SusceptibilityIn a homogeneous population of 59 patients with coro-
ary disease and mild to moderate LV dysfunction (LVEF
8  15%) without prior VT or VF, Narayan et al. (53)
onfirmed that TWA better predicted VT, VF, and total
ortality than results from EPS or LV mass over 36  12
onths, and negative TWA predicted one-year survival
90%. In an important study by Rashba et al. (68) in 144
atients with coronary disease (39% with prior VT or VF),
WA predicted this same end point over 509  387 days’
ollow-up in patients with LVEF 30% to 40% (Table 1).
otably, EPS added to the predictive value of negative and
ndeterminate TWA.
Thus, in patients with coronary disease and moderately
educed LVEF, negative TWA identifies patients in whom
mpiric ICD implantation may be less beneficial. The
ptimal approach will likely combine TWA with results
rom EPS or other indices (50). Results from the Alternans
efore Cardioverter Defibrillator study, of patients with
oronary disease and LVEF 40% who received ICDs for
ositive EPS or TWA, may, with the MASTERS study
egistry, clarify these issues.
WA in patients with non-ischemic cardiomyopathy
NICM) The Sudden Cardiac Death in Heart Failure trial
howed that patients with NICM, LVEF 35%, and heart
ailure in New York Heart Association functional classes II
nd III enjoy improved survival with empiric ICD implan-
ation over 5 years’ follow-up (5). Recent studies suggest
hat TWAmay improve risk stratification in this population
50).
In 137 patients with NICM (LVEF 29  11%), Hohn-
igure 5. Evidence-based flow chart for primary prevention of sudden car
as been validated are referenced, and labels I to III are keys to these sectio
LVEF) slightly higher than 35%, at 39  18%. See Tables 1 and 2.oser et al. (69) showed that negative TWA indicated a low oate of arrhythmic events (Table 2). This was confirmed by
itamura et al. (70) in 104 NICM patients (LVEF 37 
3%), in whom TWA onset 100 beats/min (not 110
eats/min) gave excellent negative predictive value for ar-
hythmic events (Table 2).
However, the utility of TWA in NICM has also been
uestioned. In the Marburg Cardiomyopathy study
MACAS) (Table 2) (71), neither TWA nor other noninva-
ive tests predicted arrhythmic or transplant-free survival,
lthough LVEF and lack of beta-blocker use did. Notably,
eta-blockers were withheld for TWA testing and, although
ndeterminate TWA was a univariate predictor of arrhythmic
ortality, the causes of indeterminacy were not reported.
esults from the “TWA in CHF” and “ALPHA” studies may
urther clarify the role of TWA in this population.
WA and other non-invasive stratifiers of SCA risk.
any studies have compared TWA to the signal-averaged
lectrocardiogram (SAECG). Abnormal SAECG reflects
low conduction through scarred myocardium, was shown
o predict arrhythmic events in the MUSTT study (72),
nd, therefore, may complement the repolarization index of
WA. Indeed, in 102 post-MI patients studied by Ikeda et
l. (73) (Table 2), abnormal SAECG provided higher
ositive predictive value for arrhythmic events than TWA,
hile TWA provided higher negative predictive value and
ensitivity. However, when studied by Gold et al. (12), the
AECG (RR  3.4 for arrhythmic events) was inferior to
WA (RR  6.1) in a population of whom 55% had
oronary disease. In studies by Hohnloser et al. (74),
rmoundas et al. (75), and Klingenheben et al. (76), some
rrest (SCA) including T-wave alternans (TWA). Scenarios where TWA
the text. *High-risk subgroup of (12) with left ventricular ejection fractiondiac af which included only patients with NICM (76), the
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TWA and Arrhythmia Susceptibility January 17, 2006:269–81AECG was non-predictive of arrhythmias, whereas TWA
ave an RR of 2.5, 6.8, and infinity, respectively (Tables 1
nd 2). Clearly, the utility of combining SAECG with
WA depends upon the population studied, and still
equires definitive clarification in post-MI patients.
Whether other indices add to the predictive value of
WA for SCA is less clear (50). T-wave alternans is more
redictive for SCA than widened QRS duration (13),
bnormal baroreceptor sensitivity (74,76), heart rate vari-
bility (76), or non-sustained VT (74,76). However, in a
ew studies in which TWA was non-predictive, studies
isagree on whether indices such as baroreceptor sensitivity
ere (77) or were not (71) predictive. Further studies are
eeded to define optimal combinations of risk stratifiers for
ifferent at-risk populations.
WA immediately after acute myocardial infarction.
isk stratification for SCA after MI remains difficult. The
INAMIT study (64) showed that ICD implantation
ithin 6 to 40 days of most recent MI did not reduce
ortality in patients with LVEF 35% (and elevated heart
ate or reduced heart rate variability).
T-wave alternans may predict outcome if measured 30
ays after MI, although post-MI risk stratification is itself
ifficult in populations with preserved systolic function and
orrespondingly low event rates (Table 2). In 834 patients,
keda et al. (78) showed that positive TWAmeasured 2.7
.4 months post-MI predicted SCA or resuscitated VF.
owever, when TWA was measured earlier (eight days)
fter MI by Tapanainen et al. (77), it failed to predict
ortality. A similar result was reported by Schwab et al.
79) for TWA measured 15  6 days after MI. The
lternans Cardiac Electrical Stability Study (80) examined
48 patients with LVEF 48  11% after MI, and reported
hat TWA evolves from early (5 to 21 days) to later (28 to
6 days) measurements, with 67% concordance. The Risk
stimation Following Infarction-Noninvasive Evaluation
tudy may definitively clarify the evolution of structural
isease and TWA after MI.
WA in other populations. Most cases of SCA occur in
he large healthy population of individuals who escape
urrent definitions of “high-risk” (7). Although TWA may
tratify SCA risk in subgroups of this population, such as in
thletes without structural heart disease (81), it is still most
stablished in patients with some form of heart disease.
WA IN HYPERTROPHIC CARDIOMYOPATHY (HCM). T-wave
lternans may predict outcomes in patients with HCM, in
hom indices such as EPS are less useful. In a small recent
tudy (82), TWA was more likely to be positive in patients
ith HCM than LVH with similar LV mass, and reflected
he extent of disarray on biopsy. T-wave alternans may also
dentify HCM patients at high risk for ventricular arrhyth-
ias (83).
WA AND QRS WIDENING. Left-bundle branch block pre-
icts mortality in patients with LV dysfunction (84). No-
ably, TWA was more predictive of mortality than widened tRS duration (13) in MADIT-2 type patients, although its
redictive value in the 32% of patients with QRS duration
120 ms was not reported. In addition, TWA elicited by
entricular pacing predicts inducible (10) and spontaneous
53) ventricular arrhythmias. However, in 108 patients with
oronary disease and LVEF 40%, TWA did not predict
vents if QRS duration 120 ms (85). Thus, the utility of
WA in the presence of QRS widening still requires
efinitive clarification.
WA IN THE LQTS. The utility of TWA in patients with
QTS is unclear. Visible TWA (86) is a component of the
QTS point-scoring system and reflects transmural gradi-
nts of repolarization (29). Microvolt TWA has also been
eported in LQTS 1 to 3, yet its predictive value for
rrhythmias has been questioned (87).
WA IN THE BRUGADA SYNDROME. The utility of TWA in
rugada syndrome also needs further study. In 62 patients
ith the Brugada ECG pattern, macroscopic TWA (and
T) were induced more often by the sodium channel
locker pilsicainide in patients with than without symptoms
88). Interestingly, exercise-induced TWA may not identify
ymptomatic patients (89), possibly because exercise is
nown to attenuate the Brugada phenotype.
WAANDTHEDYNAMIC RISK FOR VENTRICULAR ARRHYTH-
IAS. Recent data intriguingly suggest that TWA may
dentify dynamic arrhythmic triggers. First, TWA rises in
atients during anger recall or mental arithmetic (90), likely
eflecting heightened sympathetic tone. Second, ventricular
xtrasystoles abruptly reverse TWA phase in patients at risk
or SCA (17), which independently predicts spontaneous
rrhythmias (53). Ongoing studies may clarify the link
etween dynamic perturbations, myocardial electrical stabil-
ty, and SCA.
imitations of TWA. There are several clinical and tech-
ical limitations on the use of TWA. First, the role of
WA is unclear in patients with atrial fibrillation. The
bsence of gradual heart-rate increases with exercise has
ypically precluded its analysis (91), whereas irregular R-R
and hence QT) intervals question the validity of interpret-
ng alternans. Although preliminary studies used ventricular
acing to study TWA in patients with atrial fibrillation
53,54), further validation is needed. Second, the role of
WA is also less clear in patients with non-ischemic
ardiomyopathy and mild to moderately reduced LVEF
69,92,93), as well as in the aforementioned patients.
From a technical standpoint, the interpretation of inde-
erminate TWA must be standardized, since at present
ome studies considered indeterminate TWA as “abnormal”
labeled with the ‡ symbol in Table 1), whereas others did
ot. Attempts to reduce indeterminacy, such as measuring
WA in pacing (54), should also be explored further. One
nal limitation is that TWA analysis is currently performed
t a single point in time. Analysis of TWA over extended
ime periods, such as from ambulatory heart-rate records
(
m
C
T
o
o
T
a
w
e
T
t
w
s
s
Q
c
R
S
D
o
9
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
279JACC Vol. 47, No. 2, 2006 Narayan
January 17, 2006:269–81 TWA and Arrhythmia Susceptibility23), may extend its future utility and promote repeated
easurements.
ONCLUSIONS
-wave (repolarization) alternans is a promising ECG index
f sudden cardiac arrest that has been linked with dispersion
f repolarization and ventricular arrhythmias. Clinically,
WA has excellent negative predictive value for ventricular
rrhythmias in patients with reduced systolic function, in
hom negative TWA identifies individuals who may ben-
fit less from empiric ICD therapy. However, the value of
WA in other populations, the optimum time and condi-
ions for its measurement, and the value of combining it
ith additional risk markers need further definition. Future
tudies may establish TWA as an integral part of risk
tratification for SCA and define its role in patients with
RS widening, atrial fibrillation, and diverse etiologies for
ardiac disease.
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